American Express Anna Marrs sells 44,910 shares

The three reported sales had weighted-average prices from $326.63 to $327.77, while the exercised options carried a $148.45 exercise price.

Available on EDGAR 11/03/2026 - 04:09 PM EST Accepted by SEC EDGAR 11/03/2026 - 04:09 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

American Express Co. Group Pres., GMNS Anna Marrs reported exercising options for 44,910 common shares at a $148.45 exercise price and selling 44,910 shares on November 2, 2026. The three sales were 14,630 shares at a weighted-average $326.63, 16,833 at $327.25, and 13,447 at $327.77. A separate 22,455 Performance Stock Options vested October 31, 2026, representing the remaining 25% of an October 2022 award, based on the award's performance criteria and continued employment through that date.

Insider Trade Summary

Exercise and Sale: 44,910 shares ($8.03M approx. pre-tax spread)

Exercise and Sale 6 txns

Insider Marrs Anna

Role Group Pres., GMNS

Sold 44,910 shs ($14.69M)

Approx. gross sale proceeds $14.69M

Approx. exercise cost $6.67M

Approx. pre-tax spread $8.03M

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (Right to Buy)	44,910	$0.00	$0.00
Exercise	Common Stock F1	44,910	$148.45	$6.67M
Sale	Common Stock F2	14,630	$326.63	$4.78M
Sale	Common Stock F3	16,833	$327.25	$5.51M
Sale	Common Stock F4	13,447	$327.77	$4.41M
Grant/Award	Employee Stock Option (Right to Buy) F5	22,455	$0.00	$0.00

Holdings After Transaction: Employee Stock Option (Right to Buy) — 44,910 contracts (Direct); Common Stock — 20,508.938 shares (Direct)

Footnotes (5)

1. F1. Includes shares acquired pursuant to dividend reinvestment.
2. F2. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $326 to $326.94. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
3. F3. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $326.95 to $327.55. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
4. F4. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $327.56 to $328.47. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
5. F5. Represents the vesting of the remaining 25% of the Performance Stock Options granted to the reporting person in October 2022, based upon the satisfaction of performance criteria specified for the award at the time of grant and the reporting person's continued employment through October 31, 2026.

Key Figures

Common shares acquired through option exercise: 44,910 shares Exercise price: $148.45 per share Shares sold at weighted-average price: 14,630 shares at $326.63 per share +3 more

6 metrics

Common shares acquired through option exercise 44,910 shares Reported November 2, 2026

Exercise price $148.45 per share Options exercised November 2, 2026

Shares sold at weighted-average price 14,630 shares at $326.63 per share Reported November 2, 2026

Shares sold at weighted-average price 16,833 shares at $327.25 per share Reported November 2, 2026

Shares sold at weighted-average price 13,447 shares at $327.77 per share Reported November 2, 2026

Performance Stock Options vested 22,455 options October 31, 2026; remaining 25% of an October 2022 award

Key Terms

weighted average price, Performance Stock Options, dividend reinvestment

3 terms

weighted average price financial

"The price reported in Column 4 is a weighted average price"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Performance Stock Options financial

"remaining 25% of the Performance Stock Options granted"

dividend reinvestment financial

"shares acquired pursuant to dividend reinvestment"

Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AXP shares did Anna Marrs sell, and at what prices?

Anna Marrs sold 44,910 AXP shares on November 2, 2026, across three reported transactions. The weighted-average prices were $326.63 for 14,630 shares, $327.25 for 16,833 shares, and $327.77 for 13,447 shares; the respective reported price ranges were $326 to $326.94, $326.95 to $327.55, and $327.56 to $328.47. No Rule 10b5-1 plan is reported.

What options did Anna Marrs exercise at AXP?

Anna Marrs exercised options for 44,910 AXP common shares at a $148.45 exercise price, reported on November 2, 2026. The option record lists an exercise date of October 31, 2026, and an expiration date of October 31, 2029.

What does Anna Marrs's 22,455-option AXP award represent?

The 22,455 options represent vesting of the remaining 25% of Performance Stock Options granted in October 2022. The vesting was based on satisfaction of the award's performance criteria and continued employment through October 31, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Marrs Anna

(Last) (First) (Middle)

200 VESEY STREET, AMERICAN EXPRESS TOWER

(Street)

NEW YORK NEW YORK 10285-5001

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMERICAN EXPRESS CO [ AXP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Group Pres., GMNS

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/02/2026		M		44,910	A	$148.45	65,418.938(1)	D
Common Stock	11/02/2026		S		14,630	D	$326.63(2)	50,788.938	D
Common Stock	11/02/2026		S		16,833	D	$327.25(3)	33,955.938	D
Common Stock	11/02/2026		S		13,447	D	$327.77(4)	20,508.938	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$148.45	10/31/2026		A(5)		22,455		10/31/2026	10/31/2029	Common Stock	22,455	$0	89,820	D
Employee Stock Option (Right to Buy)	$148.45	11/02/2026		M			44,910	10/31/2026	10/31/2029	Common Stock	44,910	$0	44,910	D

Explanation of Responses:

1. Includes shares acquired pursuant to dividend reinvestment.

2. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $326 to $326.94. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

3. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $326.95 to $327.55. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

4. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $327.56 to $328.47. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

5. Represents the vesting of the remaining 25% of the Performance Stock Options granted to the reporting person in October 2022, based upon the satisfaction of performance criteria specified for the award at the time of grant and the reporting person's continued employment through October 31, 2026.

	/s/ James J. Killerlane III, attorney-in-fact	11/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)